GNFT Genfit S.A.
Healthcare$8.95+4.07%ClosedMarket Cap: $445.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-18.26
P/S
6.43
EV/EBITDA
-79.83
DCF Value
$-58.51
FCF Yield
-6.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
26.0%
Operating Margin
-84.3%
Net Margin
-127.4%
ROE
-596.4%
ROA
-54.4%
ROIC
-41.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $35.5M | 100.0% | $76.0K | $-10.0M | $— | — |
| Q4 null | $5.9M | 109.5% | $-27.9M | $-28.8M | $— | — |
| FY null | $67.0M | 99.6% | $3.3M | $1.5M | $— | — |
| Q2 null | $61.1M | 100.0% | $31.2M | $30.3M | $— | — |
| Q4 null | $14.3M | 135.8% | $-2.8M | $-8.0M | $— | — |
| FY null | $28.6M | 98.8% | $-26.6M | $-28.9M | $— | — |
| Q2 null | $11.5M | 131.6% | $-23.7M | $-20.9M | $— | — |
| Q4 null | $6.1M | 100.0% | $0.00 | $0.00 | $— | — |
| FY null | $20.2M | 98.8% | $-27.3M | $-23.7M | $— | — |
| Q2 null | $8.8M | 138.1% | $-17.5M | $-10.4M | $— | — |
| Q4 null | $80.1M | 102.6% | $58.7M | $58.2M | $— | — |
| FY null | $80.1M | 99.8% | $31.8M | $67.3M | $— | — |